The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. - Wikidata - awgldk - TriplyDB

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

http://www.wikidata.org/entity/Q34222223

about

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)Fluoroquinolones for treating tuberculosis Gender analysis of moxifloxacin clinical trials High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration.Tuberculosis, lung infections, interstitial lung disease, social issues and journalology in AJRCCM 2003.New regimens for reducing the duration of the treatment of drug-susceptible pulmonary tuberculosis.Current development and future prospects in chemotherapy of tuberculosis Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Isolation and molecular characterization of Mycobacterium bovis causing pulmonary tuberculosis and epistaxis in a Thoroughbred horse.Drug-resistant tuberculosis: controversies and challenges in pediatrics.Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis.New drugs and regimens for treatment of TB.Powerful bactericidal activity of moxifloxacin in human leprosy.Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program.Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.Chemotherapeutic interventions against tuberculosis Extensively drug-resistant tuberculosis: new strains, new challenges.Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: Part II: scientific advances that may provide solutions Antibiotic overuse and resistance in dermatology.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?The early bactericidal activity of antituberculosis drugs.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Development of new antituberculous agents based on new drug targets and structure-activity relationship.Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Assessment of the Efficacy of New Anti-Tuberculosis Drugs.Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.

P2860

Q21563671-044BF960-7051-467B-A279-F2A2EA8F3159 Q24202081-6E2FABE4-1777-4850-AC80-966B5FCC3516 Q24242773-1DF6CFF7-CD13-4518-B57B-7289C757C29D Q28538319-42963C23-3319-4E43-BA7F-CFB0C2BCBCFE Q33823864-F1E5962B-520C-4A68-ABD1-8953D4E70BAD Q33837706-2F80845F-0798-4B05-9249-C0E471FBB4C7 Q34077125-3FF02CC9-3443-4849-B791-396F59192598 Q34272283-AC81F42B-DF01-407F-AD1F-1DA018E68A4A Q34340538-BD82E3DF-9944-4873-9E45-46746EA79383 Q34777926-AEF65A0A-F392-45CC-BC0C-30271ADDE5A5 Q35127770-F673D744-790B-4D37-B786-06CB55E37E1D Q35626620-FE9AD986-ADDA-4EE6-BA79-BECE91ED4379 Q35676180-EE967C95-4DF7-40E0-95ED-0EA7BC8414E9 Q35705874-5097A039-7F8D-4248-82FE-4C4A48F9EDF2 Q35849799-B56C43E0-2471-4955-BDD5-0BAB2A54A5F3 Q35960685-BAA4D0FA-1A70-4484-8357-5F376B695FA3 Q36121974-A7F170FA-8ECA-481C-9C18-BBC1BD654E86 Q36322140-43C6374F-F458-4288-989C-FAC64323DE4C Q36650622-308BD721-4606-4F16-B9D8-93AEB66F5C68 Q36728692-20B98ADF-809B-48D5-87C5-56CD38DD187F Q36803956-50C4BB26-E51F-4D82-A69C-25E55EA5BCB3 Q36825354-DBE9DCA4-EEA8-49C5-A876-54E8451950D9 Q36870814-15B52BB4-ECB1-4515-893E-A856B1D537F7 Q36905756-D7000ADD-EB03-4C5F-94D3-DD1FE7EB0855 Q37074826-AB3FDFDB-5545-476B-B79E-FB40BC3A8EE0 Q37148764-67A8D1C5-C10E-45A1-8FCE-0E53EC891636 Q37291363-0ABA17A5-93BB-48D2-9D4B-D9157BE068E8 Q37339276-2E0E56E1-6419-4606-BBA7-7494BE848705 Q37346929-CF581A3F-38DE-4B37-8ADD-4AA0ED1C2BAA Q37624640-4C128616-A727-4D5F-A508-ABD03D08DD43 Q37742687-14A33A6C-6BDB-49CA-A193-FF91E0A8F727 Q38010519-069D6E79-47C2-4B6B-AAD9-7740174163EC Q38053000-2D715A00-95FC-4CA2-BA5D-05B1103C10F2 Q38176039-AB690F7C-CC6C-4C91-B5ED-AA1CFB74E167 Q39456569-4289F196-CCB4-44C1-BDA5-DD65843D0F27 Q39967041-EAA65F4B-7EC2-44C5-81BC-24A360B9796C Q40138610-7DBC9D2E-8B97-4DD4-BACA-50381824704C Q40363572-6F4E9723-9FE6-442F-A42E-D3A8C6A414D0 Q41572870-7986A9E1-0650-45CA-BAD4-C2F5F89E09D4 Q41987253-BB20F384-67AB-43F7-95C1-97506F15083B

P2860

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

http://www.wikidata.org/entity/Q34222223

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@ast

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@en

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@nl

type

label

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@ast

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@en

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@nl

prefLabel

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@ast

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@en

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@nl

P1433

Q34222223-C7217E8A-E715-4BCE-972A-0C752602854D

P1476

Q34222223-14058FB5-FF96-41D5-BA89-8F3931B39096

P2093

Q34222223-0B2B6074-DA6B-4AB9-A579-E9DA88AACF09

Q34222223-11C77FFC-D24F-4B1C-AA0E-8F63F991E9FD

Q34222223-3C2CC587-7167-4689-8EDF-A4AF97FE71C4

Q34222223-6708E6D2-54D7-43FD-8D6E-ACDABCF154B6

Q34222223-8E68509A-26F0-43C7-96E7-4F67BD9F2A96

Q34222223-E07C4B7B-4B89-44CC-A9C4-CF5B1618F05E

Q34222223-FDDEF7C1-C675-4D2E-B826-4C9C0FDF0687

P2860

Q34222223-15F951A4-E408-4B72-8A2C-738AE91212B1

Q34222223-171C7E9F-81CB-4785-9508-26D0BD4740F6

Q34222223-2B949138-B35B-4714-B515-3AF582C8471A

Q34222223-2DF2F931-16C4-4865-A5E2-6AACA2018168

Q34222223-3C63E862-1E75-46E1-9213-8638AF7D0122

Q34222223-3C8B99D5-9578-4516-A3C9-0156801ED294

Q34222223-6278AA40-F657-459E-8CBC-9755142169A7

Q34222223-67927514-3C42-406B-895E-946B4F032084

Q34222223-684D7772-31BC-4D8D-A821-B2AB1168FA46

Q34222223-9342C9F4-1B47-4874-BF79-E71D41AF1FFF

P304

Q34222223-35FEFFAD-4D5B-46C0-9BC0-598A526B5DDB

P31

Q34222223-4A4318F0-69AF-4F29-B1BD-15E55A1EC594

P356

Q34222223-86EA3A89-7112-4E8F-A30B-02CBCAD063D7

P407

Q34222223-B7811F57-57C8-446E-AFB8-3B32687AB70D

P433

Q34222223-EE2B94B6-23F2-47C7-89A7-06CD21126C85

P478

Q34222223-5251BF75-BA97-468F-A59F-A5463D493E39

P50

Q34222223-D3AEBDAF-CF21-425C-8B14-41B3A8444519

P577

Q34222223-F22007DB-936A-493A-86B6-92CA4AE59C72

P698

Q34222223-C402A3CC-49AB-437E-AD88-72CD3E333D99

P921

Q34222223-8179DF26-61B1-40CB-8F3B-0F9FE28C321B

Q34222223-B769F072-30E2-4405-8626-C3068FC49EC0

P356

RCCM.200305-682OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

@en

P2093

Emily Bongard

http://www.w3.org/2001/XMLSchema#string

Esther G Kanduma

http://www.w3.org/2001/XMLSchema#string

Leonard O Uiso

http://www.w3.org/2001/XMLSchema#string

Mramba Nyindo

http://www.w3.org/2001/XMLSchema#string

Noel E Sam

http://www.w3.org/2001/XMLSchema#string

Roly D Gosling

http://www.w3.org/2001/XMLSchema#string

Stephen H Gillespie

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

Activity of moxifloxacin against mycobacteria

Whither short-course chemotherapy?

A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.

In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.

Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.

Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.

Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.

A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.

P304

1342-1345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200305-682OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Richard W. Morris

P577

2003-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12917230

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde